Anticoagulation

ApprovedSmall molecule

HHospital Álvaro Cunqueiro

Anticoagulation is one of 125 small molecule programs targeting Stroke. It is currently in Approved.

Indications

Total Trials

Active Trials

124

Competitors

Pipeline

Status by Indication[3][1]

Indication

StrokeActive, not recruiting

Venous ThrombosisActive, not recruiting

Portal Vein ThrombosisActive, not recruiting

Pulmonary EmbolismActive, not recruiting

Atrial FibrillationActive, not recruiting

StrokeApproved

Active, not recruiting

Venous ThrombosisApproved

Active, not recruiting

Portal Vein ThrombosisPreclinical

Active, not recruiting

Pulmonary EmbolismPreclinical

Active, not recruiting

Atrial FibrillationPreclinical

Active, not recruiting

Competition

Competitive Landscape

461 competitors in Stroke

#DrugCompanyPhaseTrials

Anticoagulation

HHospital Álvaro Cunqueiro

Approved

1 2

Folvite

Eli Lilly

Preclinical

1 3

Proamatine

Repatha

Pradaxa

3 6

Botox

RRevance Therapeutics, Inc.

Preclinical

2 7

Periactin

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Preclinical

1 8

Alka-Seltzer

AAbbott

Preclinical

1 9

Haldol

DDePuy Orthopaedics

Preclinical

1 10

Anticoagulants

Sanofi

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

Phase 1Recruiting

Pregnancy

NCT04976465

Clinical

Trials by Indication[1]

Completed·PPenumbra Inc.·N/A·NCT05684796·100 enrolled

Stroke1 trial

ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial

Completed·UUMC Utrecht·Phase 4·NCT00161070·4,500 enrolled

Atrial Fibrillation1 trial

Retrospective Observational Registry of Patients With Atrial Fibrillation From Vigo´s Health Area

Unknown status·HHospital Álvaro Cunqueiro··NCT04364516·15,000 enrolled

3 more indications

Pregnancy1 trial

Treatment and Clinical Outcomes Among SLE Patients in Pregnancy

Recruiting·QQilu Hospital of Shandong University·Phase 1·NCT04976465·200 enrolled

Portal vein thrombosis1 trial

TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis

Unknown status·—·N/A·NCT02485184·120 enrolled

Oral Anticoagulation1 trial

Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation

Unknown status·DDeutsches Herzzentrum Muenchen·Phase 4·NCT00776633·614 enrolled

Sources

References

[1]
ClinicalTrials.gov — 8 trial records for Anticoagulation. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Anticoagulation compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Anticoagulation. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Hospital Álvaro Cunqueiro company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: HHospital Álvaro Cunqueiro

Anticoagulation

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2026

Trials by Indication[1]

Venous thrombosis1 trial